跳轉至內容
Merck
  • [Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].

[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].

Orvosi hetilap (2013-02-12)
János Tomcsányi, Kinga Jávor, Hrisula Arabadzisz, András Zsoldos, Vince Wagner, Balázs Sármán
摘要

The authors describe two cases of takotsubo cardiomyopathy developing after an abrupt withdrawal of carvedilol and bisoprolol. Takotsubo or stress cardiomyopathy is characterized by acute and reversible cardiac dysfunction without coronary artery disease. It is triggered by acute emotional or physical stress, drugs or drug withdrawal. The immediate discontinuation of the long acting vasodilator beta-blocker, carvedilol has not yet been described to cause takotsubo cardiomyopathy. The authors recommend cautious withdrawal of beta-blockers.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
比索洛尔 半富马酸盐, ≥98% (HPLC), solid
比索洛尔 半富马酸盐, European Pharmacopoeia (EP) Reference Standard
比索洛尔 半富马酸盐, European Pharmacopoeia (EP) Reference Standard